TIMD4, CETP, KRT27, PTGDS, and FAM30A were successfully validated, exhibiting higher expression levels in GC cell lines and tissues compared with GES-1 cells and normal tissues, respectively. This evidence concerns the gene FAM30A and gastric cancer.